Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/116 |
_version_ | 1818520524215549952 |
---|---|
author | Shin Dong M Zhang Hongzheng Huang Donghai Su Ling Wang Dongsheng Chen Zhuo G |
author_facet | Shin Dong M Zhang Hongzheng Huang Donghai Su Ling Wang Dongsheng Chen Zhuo G |
author_sort | Shin Dong M |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an inverse correlation between EGFR and E-cad expression in tissue specimens of squamous cell carcinoma of the head and neck (SCCHN). To understand the biological mechanisms underlying this clinical observation, we knocked down E-cad expression utilizing E-cad siRNA in four SCCHN cell lines.</p> <p>Results</p> <p>It was observed that downregulation of E-cad upregulated EGFR expression compared with control siRNA-transfected cells after 72 hours. Cellular membrane localization of EGFR was also increased. Consequently, downstream signaling molecules of the EGFR signaling pathway, p-AKT, and p-ERK, were increased at 72 hours after the transfection with E-cad siRNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed EGFR mRNA was upregulated by E-cad siRNA as early as 24 hours. In addition, RT-PCR revealed this upregulation was due to the increase of EGFR mRNA stability, but not protein stability. Sulforhodamine B (SRB) assay indicated growth of E-cad knocked down cells was enhanced up to 2-fold more than that of control siRNA-transfected cells at 72-hours post-transfection. The effect of E-cad reduction on cell proliferation was blocked by treating the E-cad siRNA-transfected cells with 1 μM of the EGFR-specific tyrosine kinase inhibitor erlotinib.</p> <p>Conclusion</p> <p>Our results suggest for the first time that reduction of E-cad results in upregulation of EGFR transcriptionally. It also suggests that loss of E-cad may induce proliferation of SCCHN by activating EGFR and its downstream signaling pathways.</p> |
first_indexed | 2024-12-11T01:38:39Z |
format | Article |
id | doaj.art-4fb8f1b297c04ee58cbda4fb085a2584 |
institution | Directory Open Access Journal |
issn | 1476-4598 |
language | English |
last_indexed | 2024-12-11T01:38:39Z |
publishDate | 2011-09-01 |
publisher | BMC |
record_format | Article |
series | Molecular Cancer |
spelling | doaj.art-4fb8f1b297c04ee58cbda4fb085a25842022-12-22T01:25:07ZengBMCMolecular Cancer1476-45982011-09-0110111610.1186/1476-4598-10-116Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFRShin Dong MZhang HongzhengHuang DonghaiSu LingWang DongshengChen Zhuo G<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an inverse correlation between EGFR and E-cad expression in tissue specimens of squamous cell carcinoma of the head and neck (SCCHN). To understand the biological mechanisms underlying this clinical observation, we knocked down E-cad expression utilizing E-cad siRNA in four SCCHN cell lines.</p> <p>Results</p> <p>It was observed that downregulation of E-cad upregulated EGFR expression compared with control siRNA-transfected cells after 72 hours. Cellular membrane localization of EGFR was also increased. Consequently, downstream signaling molecules of the EGFR signaling pathway, p-AKT, and p-ERK, were increased at 72 hours after the transfection with E-cad siRNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed EGFR mRNA was upregulated by E-cad siRNA as early as 24 hours. In addition, RT-PCR revealed this upregulation was due to the increase of EGFR mRNA stability, but not protein stability. Sulforhodamine B (SRB) assay indicated growth of E-cad knocked down cells was enhanced up to 2-fold more than that of control siRNA-transfected cells at 72-hours post-transfection. The effect of E-cad reduction on cell proliferation was blocked by treating the E-cad siRNA-transfected cells with 1 μM of the EGFR-specific tyrosine kinase inhibitor erlotinib.</p> <p>Conclusion</p> <p>Our results suggest for the first time that reduction of E-cad results in upregulation of EGFR transcriptionally. It also suggests that loss of E-cad may induce proliferation of SCCHN by activating EGFR and its downstream signaling pathways.</p>http://www.molecular-cancer.com/content/10/1/116 |
spellingShingle | Shin Dong M Zhang Hongzheng Huang Donghai Su Ling Wang Dongsheng Chen Zhuo G Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR Molecular Cancer |
title | Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR |
title_full | Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR |
title_fullStr | Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR |
title_full_unstemmed | Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR |
title_short | Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR |
title_sort | downregulation of e cadherin enhances proliferation of head and neck cancer through transcriptional regulation of egfr |
url | http://www.molecular-cancer.com/content/10/1/116 |
work_keys_str_mv | AT shindongm downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr AT zhanghongzheng downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr AT huangdonghai downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr AT suling downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr AT wangdongsheng downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr AT chenzhuog downregulationofecadherinenhancesproliferationofheadandneckcancerthroughtranscriptionalregulationofegfr |